Clinical and Applied Thrombosis/Hemostasis · 2009 · 14 citations · 6 references
MedicineEndocrinologyInternal MedicineClinical CardiologyDiabetologyHemostasisCardiovascular DiseaseCarotid Artery DiseaseDiabetes MellitusAtherosclerosis RiskAtherosclerotic Carotid StenosisCarotid Artery AtherosclerosisDiabetes-associated Vascular ChangesDiabetic ComplicationsMacrovascular ComplicationsPlasminogen ActivatorsVascular Risk Factor Assessment
Asymptomatic diabetic patients with different degrees of macrovascular complications can present different hemostatic changes. At this study, plasminogen activator inhibitor-1 (PAI-1) and D-dimer were evaluated in 12 women without diabetes and 64 type 2 diabetic women. All patients were classified into 3 different categories according to the carotid intima-media thickness (IMT) assessed by Doppler: 25 with <1 mm (normal), 15 with >1 mm and without plaque (intermediate), and 24 with stenosis lower than 50% of the vessel lumen (plaque). The results showed increased plasma D-dimer in type 2 diabetic women with carotid plaque when compared to the other groups. High levels of PAI-1 were observed in all the 3 groups of diabetic women when compared to women without diabetes. Our results suggest that high levels of PAI-1 in type 2 diabetic women are only associated with diabetes and are not associated with macrovascular progression; however, it seems that D-dimer plasma levels are associated with carotid plaque.
6
Hemostatic Markers of Endothelial Dysfunction and Risk of Incident Type 2 Diabetes
James B. Meigs, Christopher J. O’Donnell, Geoffrey H. Tofler et al. · Diabetes · 2006 · 187 citations · Full text
Medicine, Endocrinology, Diabetology +13
Coronary Heart Disease in Women With Diabetes
Glory Koerbel, Mary Korytkowski · Diabetes Spectrum · 2003 · 26 citations · Full text